Welcome
Ordering and Supplemental Information
Proficiency Testing/EQA
Quality Management Tools
Learning
Publications

Proficiency Testing/EQA / 2026 Surveys / Anatomic Pathology /
Predictive Markers

Please log in to determine if you are eligible to purchase PT Programs.
ANAPLASTIC LYMPHOMA KINASE IHC TMA - PM6
PM6
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges per Shipment Number of Shipments
Highly sensitive anaplastic lymphoma kinase IHC (ALK) 10 Two shipments per year

This program assesses the laboratory's ability to detect ALK-rearranged lung cancers using highly sensitive ALK immunohistochemistry. The ALK1 clone is not highly sensitive and should not be used in this program.


Program Information

  • One 10‑core tissue microarray slide

Shipping Schedule

  • Shipment A: March 16
  • Shipment B: August 31




Guest

Log in/Register